If you need more lookups,
subscriptions start at $34 USD/month.
Ted Tarasow Location
Pleasanton, CA, US
Ted Tarasow Work
Chief Technology Officer @ (June 2026 - Present)
Chief Product Development Officer @ (April 2025 - June 2026)
Chief Technology Officer @ (December 2022 - April 2025)
Chief Technology Officer and Founder @ (May 2020 - December 2022)
Global Head Digital Biology R and D @ (April 2018 - March 2020)
Vice President, Product Development @ HealthTell Inc. (May 2013 - April 2018)
Senior Vice President, Research and Development @ (June 2007 - May 2013)
Director, Biosecurity and Nanosciences Laboratory @ (January 2004 - December 2007)
Founder, CSO and VP Chemistry @ Invenux, Inc. (January 2000 - January 2003)
Associate Director, Medicinal Chemistry @ NeXstar Pharmaceuticals, Inc. (January 1994 - December 1999)
Ted Tarasow Education
Scripps Research 1990-1994
California Polytechnic State University-San Luis Obispo
B.S. (Chemistry)
1985-1989
Ted Tarasow Skills
Protein Chemistry
Laboratory
Validation
Biomarker Discovery
Biotechnology
FDA
Chemistry
Medicinal Chemistry
Assay Development
Molecular Biology
Biomarkers
Life Sciences
Clinical Research
Drug Discovery
Lifesciences
R&D
Pharmaceutical Industry
Research and Development R&d
u.s. Food and Drug Administration Fda
Healthcare
Customer Service
Sales
Entrepreneurship
Data Analysis
PowerPoint
Business Development
Microsoft Excel
Public Speaking
Microsoft Word
Strategic Planning
Research and Development
u.s. Food and Drug Administration
Ted Tarasow Summary
Ted Tarasow, based in Pleasanton, CA, US, is currently a Chief Technology Officer at Themis Bios. Ted Tarasow brings experience from previous roles at Themis Bios, Inscripta, Inc., Sestina Bio, LLC. and iCarbonX. Ted Tarasow holds a 1990 - 1994 Scripps Research. With a robust skill set that includes Protein Chemistry, Laboratory, Validation, Biomarker Discovery, Biotechnology and more. Ted Tarasow has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Ted Tarasow?
Find contact details for 700 million professionals.